Cargando…

“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial

(1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyawaki, Masahiro, Sano, Hiroyuki, Imbe, Hisashi, Fujisawa, Reiko, Tanimoto, Keiji, Terasaki, Jungo, Maeda-Yamamoto, Mari, Tachibana, Hirofumi, Hanafusa, Toshiaki, Imagawa, Akihisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073342/
https://www.ncbi.nlm.nih.gov/pubmed/30029523
http://dx.doi.org/10.3390/nu10070924
_version_ 1783344168119042048
author Miyawaki, Masahiro
Sano, Hiroyuki
Imbe, Hisashi
Fujisawa, Reiko
Tanimoto, Keiji
Terasaki, Jungo
Maeda-Yamamoto, Mari
Tachibana, Hirofumi
Hanafusa, Toshiaki
Imagawa, Akihisa
author_facet Miyawaki, Masahiro
Sano, Hiroyuki
Imbe, Hisashi
Fujisawa, Reiko
Tanimoto, Keiji
Terasaki, Jungo
Maeda-Yamamoto, Mari
Tachibana, Hirofumi
Hanafusa, Toshiaki
Imagawa, Akihisa
author_sort Miyawaki, Masahiro
collection PubMed
description (1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis.
format Online
Article
Text
id pubmed-6073342
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60733422018-08-13 “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial Miyawaki, Masahiro Sano, Hiroyuki Imbe, Hisashi Fujisawa, Reiko Tanimoto, Keiji Terasaki, Jungo Maeda-Yamamoto, Mari Tachibana, Hirofumi Hanafusa, Toshiaki Imagawa, Akihisa Nutrients Article (1) Background: Arteriosclerosis is associated with high levels of low-density lipoprotein (LDL) cholesterol. O-methylated catechins in “Benifuuki” green tea are expected to reduce cholesterol levels, although there is limited research regarding this topic; (2) Methods: This trial evaluated 159 healthy volunteers who were randomized to receive ice cream containing a high-dose of “Benifuuki” extract including 676 mg of catechins (group H), a low-dose of “Benifuuki” extract including 322 mg of catechins (group L), or no “Benifuuki” extract (group C). Each group consumed ice cream (with or without extract) daily for 12 weeks, and their lipid-related parameters were compared; (3) Results: A significant reduction in the level of lectin-like oxidized LDL receptor-1 ligand containing ApoB (LAB) was detected in group H, compared to groups L and C. No significant differences between the three groups were detected in their levels of total cholesterol, triglycerides, and LDL cholesterol; (4) Conclusions: “Benifuuki” extract containing O-methylated catechins may help prevent arteriosclerosis. MDPI 2018-07-19 /pmc/articles/PMC6073342/ /pubmed/30029523 http://dx.doi.org/10.3390/nu10070924 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Miyawaki, Masahiro
Sano, Hiroyuki
Imbe, Hisashi
Fujisawa, Reiko
Tanimoto, Keiji
Terasaki, Jungo
Maeda-Yamamoto, Mari
Tachibana, Hirofumi
Hanafusa, Toshiaki
Imagawa, Akihisa
“Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title_full “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title_fullStr “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title_full_unstemmed “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title_short “Benifuuki” Extract Reduces Serum Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Ligands Containing Apolipoprotein B: A Double-Blind Placebo-Controlled Randomized Trial
title_sort “benifuuki” extract reduces serum levels of lectin-like oxidized low-density lipoprotein receptor-1 ligands containing apolipoprotein b: a double-blind placebo-controlled randomized trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073342/
https://www.ncbi.nlm.nih.gov/pubmed/30029523
http://dx.doi.org/10.3390/nu10070924
work_keys_str_mv AT miyawakimasahiro benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT sanohiroyuki benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT imbehisashi benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT fujisawareiko benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT tanimotokeiji benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT terasakijungo benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT maedayamamotomari benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT tachibanahirofumi benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT hanafusatoshiaki benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial
AT imagawaakihisa benifuukiextractreducesserumlevelsoflectinlikeoxidizedlowdensitylipoproteinreceptor1ligandscontainingapolipoproteinbadoubleblindplacebocontrolledrandomizedtrial